Cohu to Participate in 14th Annual NYC Summit Investor Conference on December 16, 2025
- Investor Conference Participation: Cohu will participate in the 14th Annual NYC Summit on December 16, 2025, at Mastro's in New York, showcasing its technological advantages in semiconductor manufacturing to attract more investor interest in its business development.
- Conference Format Explanation: The NYC Summit features a
Trade with 70% Backtested Accuracy
Analyst Views on COHU
About COHU
About the author
Analysts Upgrade Core Scientific to Buy with $23 Price Target
- Rating Upgrade: BTIG analyst Gregory Lewis upgraded Core Scientific Inc (NASDAQ:CORZ) from Neutral to Buy with a price target of $23, reflecting confidence in the company's future growth potential.
- Market Performance: Core Scientific shares closed at $16.73 on Monday, indicating a potential upside of 37.5% to the analyst's target price, which may attract more investor interest in the stock.
- Industry Trends: This rating change aligns with market expectations of a rebound in blockchain and cryptocurrency mining demand, indicating analysts' optimism about the industry's recovery.
- Investor Confidence: The positive rating from analysts could enhance investor confidence in Core Scientific, potentially driving the stock price up and improving the company's financing environment.
TER Benefits from Robust Semiconductor Testing Sector: Is Further Growth on the Horizon?
Teradyne's Growth in Semiconductor Testing: Teradyne's Semiconductor Test revenues increased by 7% year-over-year and 23% sequentially in Q3 2025, driven by rising demand for AI-related products and significant contributions from memory test sales, particularly DRAM and flash memory.
Competitive Landscape: Teradyne faces competition from Advantest and Cohu, both of which are expanding their semiconductor test offerings to meet the growing demand for high-performance AI-related semiconductors.
Stock Performance and Valuation: Teradyne's shares have surged 137.5% over the past six months, outperforming industry averages, but the stock is trading at a premium with a forward Price/Sales ratio of 8.68X compared to the industry average of 6.99X.
Future Outlook and AI Investment: The consensus for Teradyne's fiscal 2026 earnings suggests a 9.01% year-over-year growth, and analysts predict that the next phase of AI development will create significant investment opportunities, highlighting the potential for new companies to emerge as leaders in the sector.
